Retatrutide Assessed for Weight Loss in Obesity Study | Retatrutide News
A study is evaluating retatrutide for weight loss in obese or overweight individuals. The trial involves 65 weeks and 18 visits.
Clinical Trials · October 16, 2026
A study is evaluating retatrutide for weight loss in obese or overweight individuals. The trial involves 65 weeks and 18 visits.
Clinical Trials · October 16, 2026